Patents by Inventor Marc Ballas

Marc Ballas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Treating Late Stage Lung Cancer
    Publication number: 20220073622
    Abstract: Disclosed are methods for treating late stage (e.g., clinical stage III or IV), unresectable non-small-cell lung cancer (NSCLC) with an antibody that inhibits PD1/PD-L1 activity in a patient identified as having not progressed following definitive chemoradiation therapy.
    Type: Application
    Filed: November 18, 2021
    Publication date: March 10, 2022
    Inventors: Giovanni Melillo, Marc Ballas, Simon Dovedi, Ross Stewart
  • COMPOSITIONS AND METHODS FOR TREATING LATE STAGE LUNG CANCER
    Publication number: 20190276543
    Abstract: Disclosed are methods for treating late stage (e.g., clinical stage III or IV), unresectable non-small-cell lung cancer (NSCLC) with an antibody that inhibits PD1/PD-L1 activity in a patient identified as having not progressed following definitive chemoradiation therapy.
    Type: Application
    Filed: March 8, 2018
    Publication date: September 12, 2019
    Inventors: Giovanni Melillo, Marc Ballas, Simon Dovedi, Ross Stewart
  • COMBINATION THERAPY FOR PD-L1 NEGATIVE TUMORS
    Publication number: 20160060344
    Abstract: The present invention features methods of treating lung cancer (e.g., NSCLC) with an anti-PD-L1 antibody and tremelimumab in a subject identified as having a PD-L1 negative tumor.
    Type: Application
    Filed: August 28, 2015
    Publication date: March 3, 2016
    Inventors: Rajesh Narwal, Marlon C. Rebelatto, Keith Steele, Paul Robbins, Ross Anthony Stewart, John A. Blake-Haskins, Joyson J. Karakunnel, Ramy Ibrahim, Aiman Shalabi, Alessandra Di Pietro, Li Shi, Shengyan Hong, Paul Stockman, Marc Ballas, Mohammed M. Dar